Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Top Cited Papers
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 34 (3) , 193-205
- https://doi.org/10.1016/j.ctrv.2007.12.001
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Rising Incidence of Small Renal Masses: A Need to Reassess Treatment EffectJNCI Journal of the National Cancer Institute, 2006
- Treatment for renal cancer: are we beyond the cytokine era?Nature Reviews Endocrinology, 2006
- Do Oncologists Believe New Cancer Drugs Offer Good Value?The Oncologist, 2006
- Targeted agents for the treatment of advanced renal cell carcinomaCancer, 2005
- Renal cell carcinomaCurrent Opinion in Oncology, 2005
- Novel approaches in the therapy of metastatic renal cell carcinomaWorld Journal of Urology, 2005
- Renal cell carcinomaCurrent Opinion in Oncology, 2004
- Quality of life aspects in kidney cancer patients: data from a national registrySupportive Care in Cancer, 2003
- A phase II study of interferon‐α, interleukin‐2 and 5‐fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activationBritish Journal of Urology, 1996